Triterpenoid saponins from the roots of two Gypsophila species. 2014

David Pertuit, and Sibel Avunduk, and Anne-Claire Mitaine-Offer, and Tomofumi Miyamoto, and Chiaki Tanaka, and Thomas Paululat, and Stéphanie Delemasure, and Patrick Dutartre, and Marie-Aleth Lacaille-Dubois
Laboratoire de Pharmacognosie, EA 4267, FDE/UFC, UFR Pharmacie, Université de Bourgogne, 7, Bd Jeanne d'Arc, BP 87900, 21079 Dijon Cedex, France.

Two triterpenoid saponins with two known ones have been isolated from the roots of Gypsophila arrostii var. nebulosa, and two new ones from the roots of Gypsophila bicolor. Their structures were established by extensive NMR and mass spectroscopic techniques as 3-O-β-d-galactopyranosyl-(1→2)-[β-d-xylopyranosyl-(1→3)]-β-d-glucuronopyranosylquillaic acid 28-O-β-d-xylopyranosyl-(1→4)-[β-d-glucopyranosyl-(1→3)]-α-l-rhamnopyranosyl-(1→2)-[β-d-glucopyranosyl-(1→4)]-β-d-fucopyranosyl ester (1), 3-O-β-d-galactopyranosyl-(1→2)-[β-d-xylopyranosyl-(1→3)]-β-d-glucuronopyranosylgypsogenin 28-O-β-d-xylopyranosyl-(1→4)-[β-d-glucopyranosyl-(1→3)]-α-l-rhamnopyranosyl-(1→2)-[β-d-glucopyranosyl-(1→4)]-β-d-fucopyranosyl ester (2), 3-O-β-d-galactopyranosyl-(1→2)-[β-d-xylopyranosyl-(1→3)]-β-d-glucuronopyranosylgypsogenin 28-O-β-d-xylopyranosyl-(1→3)-β-d-xylopyranosyl-(1→4)-α-l-rhamnopyranosyl-(1→2)-[(4-O-acetyl)-β-d-quinovopyranosyl-(1→4)]-β-d-fucopyranosyl ester (3), gypsogenic acid 28-O-β-d-glucopyranosyl-(1→3)-{6-O-[3-hydroxy-3-methylglutaryl]-β-d-glucopyranosyl-(1→6)}-β-d-galactopyranosyl ester (4). Three compounds were evaluated against one human colon cancer cell line SW480 and one rat cardiomyoblast cell line H9c2.

UI MeSH Term Description Entries
D008968 Molecular Conformation The characteristic three-dimensional shape of a molecule. Molecular Configuration,3D Molecular Structure,Configuration, Molecular,Molecular Structure, Three Dimensional,Three Dimensional Molecular Structure,3D Molecular Structures,Configurations, Molecular,Conformation, Molecular,Conformations, Molecular,Molecular Configurations,Molecular Conformations,Molecular Structure, 3D,Molecular Structures, 3D,Structure, 3D Molecular,Structures, 3D Molecular
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D012503 Saponins A type of glycoside widely distributed in plants. Each consists of a sapogenin as the aglycone moiety, and a sugar. The sapogenin may be a steroid or a triterpene and the sugar may be glucose, galactose, a pentose, or a methylpentose. Saponin
D013045 Species Specificity The restriction of a characteristic behavior, anatomical structure or physical system, such as immune response; metabolic response, or gene or gene variant to the members of one species. It refers to that property which differentiates one species from another but it is also used for phylogenetic levels higher or lower than the species. Species Specificities,Specificities, Species,Specificity, Species

Related Publications

David Pertuit, and Sibel Avunduk, and Anne-Claire Mitaine-Offer, and Tomofumi Miyamoto, and Chiaki Tanaka, and Thomas Paululat, and Stéphanie Delemasure, and Patrick Dutartre, and Marie-Aleth Lacaille-Dubois
January 1991, Phytochemistry,
David Pertuit, and Sibel Avunduk, and Anne-Claire Mitaine-Offer, and Tomofumi Miyamoto, and Chiaki Tanaka, and Thomas Paululat, and Stéphanie Delemasure, and Patrick Dutartre, and Marie-Aleth Lacaille-Dubois
June 2013, Phytochemistry,
David Pertuit, and Sibel Avunduk, and Anne-Claire Mitaine-Offer, and Tomofumi Miyamoto, and Chiaki Tanaka, and Thomas Paululat, and Stéphanie Delemasure, and Patrick Dutartre, and Marie-Aleth Lacaille-Dubois
January 2010, Carbohydrate research,
David Pertuit, and Sibel Avunduk, and Anne-Claire Mitaine-Offer, and Tomofumi Miyamoto, and Chiaki Tanaka, and Thomas Paululat, and Stéphanie Delemasure, and Patrick Dutartre, and Marie-Aleth Lacaille-Dubois
October 2011, Carbohydrate research,
David Pertuit, and Sibel Avunduk, and Anne-Claire Mitaine-Offer, and Tomofumi Miyamoto, and Chiaki Tanaka, and Thomas Paululat, and Stéphanie Delemasure, and Patrick Dutartre, and Marie-Aleth Lacaille-Dubois
October 1995, Journal of natural products,
David Pertuit, and Sibel Avunduk, and Anne-Claire Mitaine-Offer, and Tomofumi Miyamoto, and Chiaki Tanaka, and Thomas Paululat, and Stéphanie Delemasure, and Patrick Dutartre, and Marie-Aleth Lacaille-Dubois
March 2010, Chemical & pharmaceutical bulletin,
David Pertuit, and Sibel Avunduk, and Anne-Claire Mitaine-Offer, and Tomofumi Miyamoto, and Chiaki Tanaka, and Thomas Paululat, and Stéphanie Delemasure, and Patrick Dutartre, and Marie-Aleth Lacaille-Dubois
February 1997, Phytochemistry,
David Pertuit, and Sibel Avunduk, and Anne-Claire Mitaine-Offer, and Tomofumi Miyamoto, and Chiaki Tanaka, and Thomas Paululat, and Stéphanie Delemasure, and Patrick Dutartre, and Marie-Aleth Lacaille-Dubois
December 1998, Journal of natural products,
David Pertuit, and Sibel Avunduk, and Anne-Claire Mitaine-Offer, and Tomofumi Miyamoto, and Chiaki Tanaka, and Thomas Paululat, and Stéphanie Delemasure, and Patrick Dutartre, and Marie-Aleth Lacaille-Dubois
March 2008, Bioorganic & medicinal chemistry,
David Pertuit, and Sibel Avunduk, and Anne-Claire Mitaine-Offer, and Tomofumi Miyamoto, and Chiaki Tanaka, and Thomas Paululat, and Stéphanie Delemasure, and Patrick Dutartre, and Marie-Aleth Lacaille-Dubois
April 2007, Chemical & pharmaceutical bulletin,
Copied contents to your clipboard!